ArticleHuman molecular genetics2025

Silencing of SOD1 sensitises ATRX-deficient cells to camptothecin treatment through increased activity of the alternative lengthening of telomeres pathway.

Natalie Mattis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.